Abbott Molecular Inc:医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Abbott Molecular Inc - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C6601
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:18
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Abbott Molecular Inc (Abbott Molecular), formerly Vysis Inc, a subsidiary of Abbott Laboratories, is a medical diagnostics company that provides molecular testing solutions. The company offers infectious disease products, oncology products, genetics products, automation products, molecular diagnostics and assays. It provide PathVysion HER-2 DNA Probe kits, ALK break apart FISH probe kits, and UroVysion bladder cancer kits. Abbott Molecular also offers multi collect specimen collection kits, amplification reagent kits, control kits, HBV application CD-ROM, HBV calibrator and control kits, antifade solutions, CGH hybridization reagents, and FISH pretreatment reagent kits, among others. The company’s therapeutic areas include breast cancer, automation, genetics, infectious disease, and oncology. It has presence in Africa, Asia, Europe, North America, South America and others. Abbott Molecular is headquartered in Des Plaines, Illinois, the US.

Abbott Molecular Inc – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Abbott Molecular Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Abbott Molecular Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Abbott Molecular Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Abbott Molecular Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Abbott Molecular Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Abbott Molecular Inc, Medical Equipment, Deal Details 10
Partnerships 10
Abbott Molecular Enters into Co-Development Agreement with Biocartis 10
Idera Pharma Enters Into Co-Development Agreement With Abbott Molecular For In Vitro Companion Diagnostic Test 11
BioGenex Labs Enters Into Co-Marketing Agreement With Abbott Molecular 12
Abbott Molecular Enters Into Agreement With Janssen Biotech And Pharmacyclics For Leukemia Test 13
BioView Enters Into Agreement With Abbott To Develop Automated Cancer Screening System 14
Abbott Molecular Inc – Key Competitors 15
Abbott Molecular Inc – Key Employees 16
Abbott Molecular Inc – Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18

List of Tables
Abbott Molecular Inc, Medical Equipment, Key Facts 2
Abbott Molecular Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Abbott Molecular Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Abbott Molecular Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Abbott Molecular Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Abbott Molecular Inc, Deals By Market, 2012 to YTD 2018 8
Abbott Molecular Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Abbott Molecular Enters into Co-Development Agreement with Biocartis 10
Idera Pharma Enters Into Co-Development Agreement With Abbott Molecular For In Vitro Companion Diagnostic Test 11
BioGenex Labs Enters Into Co-Marketing Agreement With Abbott Molecular 12
Abbott Molecular Enters Into Agreement With Janssen Biotech And Pharmacyclics For Leukemia Test 13
BioView Enters Into Agreement With Abbott To Develop Automated Cancer Screening System 14
Abbott Molecular Inc, Key Competitors 15
Abbott Molecular Inc, Key Employees 16
Abbott Molecular Inc, Other Locations 17

List of Figures
Abbott Molecular Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Abbott Molecular Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Abbott Molecular Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Abbott Molecular Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Abbott Molecular Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Abbott Molecular Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Abbott Molecular Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Abbott Molecular Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Abbott Molecular Inc:医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Innoviva Inc (INVA):企業の財務・戦略的SWOT分析
    Innoviva Inc (INVA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Prairie Provident Resources Inc (PPR):石油・ガス:M&Aディール及び事業提携情報
    Summary Prairie Provident Resources Inc (Prairie Provident) is an exploration and development company that develops oil and natural gas assets. The company offers exploration and development of oil and natural gas with conventional operations primarily focused in the Western Canadian Sedimentary Bas …
  • Wentworth Resources Ltd (WRL):企業の財務・戦略的SWOT分析
    Wentworth Resources Ltd (WRL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Digital Locations Inc (CABN):企業の財務・戦略的SWOT分析
    Summary Digital Locations Inc (Digital Locations), is a provider of software solutions. It is a developer of cell tower sites for the 5G revolution. The company's 5G wireless networks provide applications include the Internet of things (IOT), self-driving cars, real-time hologram-based collaboration …
  • Cosmo Pharmaceuticals NV (COPN):医療機器:M&Aディール及び事業提携情報
    Summary Cosmo Pharmaceuticals NV (Cosmo) is a pharmaceutical company that develops drugs for the treatment of gastro-intestinal diseases. The company develops its pharmaceutical products based on its multi matrix technology. Its proprietary clinical development pipeline intended for the treatment of …
  • Nufarm Limited (NUF):企業の財務・戦略的SWOT分析
    Nufarm Limited (NUF) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Baosteel Group Corporation:企業のM&A・事業提携・投資動向
    Baosteel Group Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Baosteel Group Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acqui …
  • First Midwest Bancorp, Inc.:企業の戦略・SWOT・財務情報
    First Midwest Bancorp, Inc. - Strategy, SWOT and Corporate Finance Report Summary First Midwest Bancorp, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Empresas Publicas De Medellin ESP:企業の戦略的SWOT分析
    Empresas Publicas De Medellin ESP - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major p …
  • Kura Oncology Inc (KURA):企業の財務・戦略的SWOT分析
    Summary Kura Oncology Inc (Kura Oncology) is a clinical-stage biopharmaceutical company that discovers and develops therapeutics for the treatment of solid tumors and blood cancers. The company’s lead drug candidate Tipifarnib, an inhibitor of farnesyl transferase, an oral investigational drug candi …
  • Agnico-Eagle Mines Ltd:企業のM&A・事業提携・投資動向
    Agnico-Eagle Mines Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Agnico-Eagle Mines Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions …
  • Penske Corporation:企業の戦略的SWOT分析
    Penske Corporation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • Singulus Technologies AG (SNG):電力:M&Aディール及び事業提携情報
    Summary Singulus Technologies AG (Singulus Technologies) is an optical disc production line manufacturer that develops technologies for efficient and resource-conserving production processes. The company offers optical disc solutions such as blu-ray disc, CD, and DVD production equipment. Its solar …
  • DAIS Corp (DLYT):企業の財務・戦略的SWOT分析
    Summary Dais Corps (Dais) is an alternative energy company. It provides industry changing and nano technology based applications. The company's products include ultra capacitors, clean water systems, heating and cooling equipment, among others. It also provides NanoAir, NanoCap, ConsERV and NanoClea …
  • Tsumura & Co.:企業の戦略・SWOT・財務情報
    Tsumura & Co. - Strategy, SWOT and Corporate Finance Report Summary Tsumura & Co. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Dr. Paul Lohmann GmbH KG:企業の戦略・SWOT・財務情報
    Dr. Paul Lohmann GmbH KG - Strategy, SWOT and Corporate Finance Report Summary Dr. Paul Lohmann GmbH KG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Nissan Chemical Corp (4021):企業の財務・戦略的SWOT分析
    Nissan Chemical Corp (4021) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • CLP Holdings Limited:発電所・企業SWOT分析
    CLP Holdings Limited - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employee …
  • Insightra Medical Inc-医療機器分野:企業M&A・提携分析
    Summary Insightra Medical Inc (Insightra Medical), a subsidiary of GPB Life Science Holdings LLC is a medical device company that develops disposable devices. The company offers cardiovascular and surgical solutions. Its cardiovascular solutions include Ultra 7FR IAB and modulare. The Modulare Cathe …
  • PTC Inc.:企業の戦略・SWOT・財務情報
    PTC Inc. - Strategy, SWOT and Corporate Finance Report Summary PTC Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆